Ming Qiu

Prof. Dr. Ming Qiu

Shanghai Changzheng Hospital, Shanghai, China
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2019 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
XWXingzhu Wen
Xingzhu Wen
BWBin Wang
Bin Wang
QJQianmei Jin
Qianmei Jin
WZWei Zhang
Wei Zhang
MQMing Qiu
Ming Qiu

1 April 2022 in World Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
XWXingzhu Wen
Xingzhu Wen
QJQianmei Jin
Qianmei Jin
XCXiaoxia Cen
Xiaoxia Cen
MQMing Qiu
Ming Qiu
ZWZhihong Wu
Zhihong Wu
Background: The presence of central lymph node metastases (CLNM) has been suggested as a risk factor for poorer prognosis and recurrence in papillary thyroid microcarcinoma (PTMC). However, the clinicopathologic factors for CLNM in clinical node-negative (CN0) PTMC were not well defined. This study aimed to perform a systematic review and meta-analysis to investigate the significant clinicopathologic predictors of CLNM in CN0 PTMC. Methods: A systematic literature search was performed in PubMed, Embase, Cochrane Library, and Web of Science. Case-control studies on the association of clinicopathologic risk factors with CLNM in CN0 PTMC were included. Results: Thirteen eligible studies involving 6068 patients with CN0 PTMC were included. From the pooled analyses, male (odds ratio [OR]: 2.07, 95% CI: 1.49–2.87, P < 0.001), multifocality (OR: 1.88, 95% CI: 1.54–2.29, P < 0.001), tumor size > 5 mm (OR: 1.84, 95% CI: 1.55–2.18, P < 0.001), and extrathyroidal extension (OR: 1.96, 95% CI: 1.30–2.95, P = 0.001) are significantly associated with increased risk of CLNM in CN0 PTMC. A sample size with a cutoff point of 200 was identified as the source of heterogeneity for sex according to meta-regression (t = 3.18, P = 0.033). Then, the subgroup analysis of male was performed, which illustrated that male increased the risk of CLNM in the small sample group (SG) and the large sample group (LG) by 6.11-folds and 2.01-folds, respectively (SG: OR, 6.11, 95% CI, 3.16–11.81, P < 0.001; LG: OR, 2.01, 95% CI, 1.65–2.46, P < 0.001). Conclusions: Male, multifocality, tumor size > 5 mm, and extrathyroidal extension may be reliable clinical predictors of CLNM in CN0 PTMC. Moreover, prophylactic central lymph node dissection should be considered in surgical decision-making for CN0 PTMC patients, who are male, multifocal, with tumor size > 5 mm, and with extrathyroidal extension. Trial registration: CRD42021242211 (PROSPERO)

26 October 2022 in Frontiers in Endocrinology
Verified
Journal Article
Open access
WLWei Li
Wei Li
ZLZhiyong Liu
Zhiyong Liu
XCXiaoxia Cen
Xiaoxia Cen
JXJing Xu
Jing Xu
SZSuo Zhao
Suo Zhao
MQMing Qiu
Ming Qiu
Background: Papillary thyroid cancer (PTC) is the most common pathological type of thyroid cancer with a high incidence globally. Increasing evidence reported that fibroblasts infiltration in cancer was correlated with prognostic outcomes. However, fibroblasts related study in thyroid cancer remains deficient.Methods: Single-cell sequencing data of PTC were analyzed by Seurat R package to explore the ecosystem in PTC and identify fibroblasts cluster. The expression profiles and prognostic values of fibroblast related genes were assessed in TCGA dataset. A fibrosis score model was established for prognosis prediction in thyroid cancer patients. Differentially expressed genes and functional enrichment between high and low fibrosis score groups in TCGA dataset were screened. The correlation of immune cells infiltration and fibrosis score in thyroid cancer patients was explored. Expression levels and prognostic values of key fibroblast related factor were validated in clinical tissues another PTC cohort.Results: Fibroblasts were highly infiltrated in PTC and could interact with other type of cells by single-cell data analysis. 34 fibroblast related terms were differentially expressed in thyroid tumor tissues. COX regression analysis suggested that the constructed fibrosis score model was an independent prognostic predictor for thyroid cancer patients (HR = 5.17, 95%CI 2.31-11.56, P = 6.36E-05). Patients with low fibrosis scores were associated with a significantly better overall survival (OS) than those with high fibrosis scores in TCGA dataset (P = 7.659E-04). Specific immune cells infiltration levels were positively correlated with fibrosis score, including monocytes, M1 macrophages and eosinophils.Conclusion: Our research demonstrated a comprehensive horizon of fibroblasts features in thyroid cancer microenvironment, which may provide potential value for thyroid cancer treatment.

1 January 2019 in Journal of Otolaryngology - Head & Neck Surgery
Verified
Journal Article
Open access
PDF file
BWBin Wang
Bin Wang
XWXing-Zhu Wen
Xing-Zhu Wen
WZWei Zhang
Wei Zhang
MQMing Qiu
Ming Qiu
Background: To evaluate the possible predictive value and clinicopathological characteristics of Delphian lymph node metastasis in papillary thyroid carcinoma. Methods: A retrospective analysis of papillary thyroid carcinoma patients with Delphian lymph node metastasis in a single institution and meta-analysis of literature reports were performed. Results: In own series, Delphian lymph node metastasis was detected in 19 (9.9%) of 192 papillary thyroid carcinoma patients and was significantly associated with tumor size≥1 cm ( P = 0.003), multifocality ( P = 0.006) and extrathyroid extension ( P < 0.001) in the multivariate analysis. Female was a protective factor for Delphian lymph node metastasis ( P = 0.001). Delphian lymph node metastasis was highly predictive of further central lymph node metastasis (positive predictive value = 89.5%, negative predictive value = 67.6%) and moderately predictive of lateral lymph node metastasis (positive predictive value = 26.3%, negative predictive value = 95.4%). In this meta-analysis, there was a strong correlation between Delphian lymph node metastasis and aggressive clinicopathologic characteristics with regards to multifocality ( P = 0.0008), bilaterality ( P = 0.04), extrathyroid extension ( P < 0.00001), lymphovascular invasion ( P < 0.00001), further central lymph node metastasis ( P < 0.00001) and lateral lymph node metastasis ( P < 0.00001). Conclusions: This single-institution observational study and meta-analysis identified that Delphian lymph node metastasis was significantly associated with unfavorable clinicopathological characteristics and had a strong predictive power for further disease in the central compartment. Trial registration: The clinical study was retrospectively registered to UMIN clinical trials registry (the registry number: UMIN000033835 ).

1 May 2019 in International Journal of Surgery
Verified
Journal Article
Closed access
WLWei Li
Wei Li
BWBin Wang
Bin Wang
ZJZhi-Guo Jiang
Zhi-Guo Jiang
YFYun-Jie Feng
Yun-Jie Feng
WZWei Zhang
Wei Zhang
MQMing Qiu
Ming Qiu
Background: The clinical value of thymus preservation during thyroid carcinoma surgery remains unclear. The aim of this study is to explore the role of bilateral thymus preservation in parathyroid glands (PGs) function and surgical completeness in total thyroidectomy (TT) with bilateral central lymph node dissection (CLND). Materials and methods: Fifty-four consecutive patients who underwent TT and bilateral CLND were assigned to the thymus preservation (TP) group (n=27) and the bilateral thymectomy (BT) group (n=27). Surgical completeness was evaluated by the number of lymph nodes dissected, serum Tg level and ultrasound findings postoperatively. Results: Incidental parathyroidectomy was more common in the BT group (29.6% vs 7.4%, p=0.038). Patients in the BT group had higher risks of neuromuscular symptoms (63.0% vs 29.6%, P=0.014) and transient hypoparathyroidism (70.4% vs 25.9%, P=0.001). The incidence of persistent hypoparathyroidism failed to show a significant difference between the TP and BT groups (0 vs 14.8%, P=0.111). However, those with transient hypoparathyroidism in the BT group had a lower level of serum PTH at 3 weeks postoperatively (p=0.001). There was no significant difference in the number of lymph nodes dissected (5.89 +/- 3.12 vs 8.56 +/- 6.93, P=0.077) and preablation sTg level (1.82 +/- 2.18 vs 1.42 +/- 1.56 ng/ml, P=0.775) between the TP and BT groups. No metastatic lymph nodes were found on sonography at 3 months postoperatively in both groups. Conclusion: Thymus preservation had benefits on protecting PGs and promoting rapid clinical resolution of hypoparathyroidism. It had no effects on oncologic completeness of TT with bilateral CLND.

29 April 2020 in The American Journal of Surgery
Verified
Journal Article
Closed access
PDF file
WLWei Li
Wei Li
BLBingyang Liu
Bingyang Liu
CSChengxiang Shan
Chengxiang Shan
ZLZhiyong Liu
Zhiyong Liu
QWQiang Wang
Qiang Wang
MQMing Qiu
Ming Qiu